Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development Announce the Formation of Vitesse Biologics, LLC, a Company Structured to Accelerate Therapeutic Innovation

Vitesse formed to identify and advance early stage biologic research in immunology, hematology and oncology Deerfield, IL., Rochester, MN and South San Francisco, CA. — Baxter Ventures, the venture arm of Baxter International Inc. (NYSE:BAX), Mayo Clinic and Velocity Pharmaceutical Development, LLC (“VPD”) today announced the formation of Vitesse Biologics, LLC, (“Vitesse”). Vitesse is a [...]
Source: Mayo Clinic Business News - Category: Pharmaceuticals Source Type: news